Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

414 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hematopoietic Stem Cell Transplantation in Children with Inborn Errors of Immunity: a Multi-center Experience in Colombia.
Olaya M, Franco A, Chaparro M, Estupiñan M, Aristizabal D, Builes-Restrepo N, Franco JL, Zea-Vera AF, Estacio M, Manzi E, Beltran E, Perez P, Patiño J, Pachajoa H, Medina-Valencia D. Olaya M, et al. Among authors: chaparro m. J Clin Immunol. 2020 Nov;40(8):1116-1123. doi: 10.1007/s10875-020-00856-w. Epub 2020 Sep 2. J Clin Immunol. 2020. PMID: 32880086
[Colombian Guidelines of clinical practice for the use of immunoglobulins in the treatment of replacement and immunomodulation].
Olivares MM, Olmos CE, Álvarez MI, Fajardo AM, Zea-Vera AF, Ortega MC, Medina D, Pérez PM, Beltrán DG, Duque B, Álvarez CA, Lenis G, Solano JM, Gómez D, Franco JL, Díaz MC, Orrego JC, Velásquez MM, Chaparro M, Pinto JL, Izquierdo Á, Ramírez SF. Olivares MM, et al. Among authors: chaparro m. Rev Alerg Mex. 2017;64 Suppl 2:s5-s65. doi: 10.29262/ram.v64i0.300. Rev Alerg Mex. 2017. PMID: 28863425 Spanish.
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.
Gisbert JP, Donday MG, Riestra S, Lucendo AJ, Benítez JM, Navarro-Llavat M, Barrio J, Morales-Alvarado VJ, Rivero M, Busquets D, Leo Carnerero E, Merino O, Nantes Castillejo Ó, Navarro P, Van Domselaar M, Gutiérrez A, Alonso-Abreu I, Mejuto R, Fernández-Salazar L, Iborra M, Martín-Arranz MD, Pineda JR, Sampedro MJ, Serra Nilsson K, Bouhmidi A, Batista L, Muñoz Villafranca C, Rodríguez-Lago I, Ceballos D, Guerra I, Mañosa M, Marín Jiménez I, Torrella E, Vera Mendoza M, Casanova MJ, de Francisco R, Arias-González L, Marín Pedrosa S, García-Bosch O, García-Alonso FJ, Delgado-Guillena P, García MJ, Torrealba L, Núñez-Ortiz A, Vicuña Arregui M, Bosca-Watts MM, Blázquez I, Acosta D, Garre A, Baldán M, Martínez C, Barreiro-de Acosta M, Domènech E, Esteve M, García-Sánchez V, Nos P, Panés J, Chaparro M; EXIT Study group of GETECCU. Gisbert JP, et al. Among authors: chaparro m. Gut. 2024 Dec 20:gutjnl-2024-333385. doi: 10.1136/gutjnl-2024-333385. Online ahead of print. Gut. 2024. PMID: 39794921 Free article.
414 results